Responsibility Responsible business is how we do business
Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. To achieve this mission we are adapting our business model and pursuing a strategy that delivers sustainable performance through innovation and expanding access, driven by our values.
Our commitments
We have 23 forward-looking commitments across the four areas of our responsible business approach. They aim to address global health needs and are aligned with our strategic priorities and our values.
To find out how we are progressing against our commitments, visit our Health for all, Our behaviour, Our people and Our planet sections.
-
Health for all
Our part in tackling global health challenges and our aim to extend the benefits of our products to more people
-
Our behaviour
We are changing the way we work to further embed our values in everything we do, including the way we research, develop, sell and market our products
-
Our people
Learn how we create an inspiring and supportive work environment that encourages employees to develop capabilities and achieve their best
-
Our planet
To ensure we deliver high quality products to patients and consumers, we must protect the natural resources we need to make them today
Changing the face of healthcare GSK
By working in partnership, we hope to overcome some of the biggest challenges in global health.
We are adapting our business model and pursuing a strategy that delivers sustainable performance through innovation and expanding access, driven by our values.
We report key information on our approach to responsible business in our Responsible Business Supplement alongside our financial performance within the Annual Report.
Community focus
Our governance structure
Our Board-level Corporate Responsibility Committee (CRC) oversees our responsible business activities. It meets four times a year to provide high-level guidance and reviews performance against our commitments. Both the Chairman and CEO are among its members and Non-Executive Director, Lynn Elsenhans, is Chair of the CRC.
Management of key non-financial risks is governed by our Audit and Risk Committee. The Audit and Assurance team supports this committee by providing an independent view to the Board and senior management of how risk is being managed across the business consistent with an agreed Assurance Plan.
Your feedback counts
We welcome your feedback on our responsible business performance and reporting. You can also request to receive regular updates on our progress. Please contact us at csr.contact@gsk.com